Rocket Pharmaceuticals IncMost RecentHealthcareGene Therapy Pipeline May Drive Rocket Pharmaceuticals’ GrowthRocket Pharmaceuticals (RCKT) has reported year-to-date returns of 140.52%.
HealthcareGene Therapy Pipeline May Drive Rocket Pharmaceuticals’ GrowthRocket Pharmaceuticals (RCKT) has reported year-to-date returns of 140.52%.
